About this trial
Taking part in medical research usually favors a particular demographic group. But there is limited research available to explain what trial attributes affect the completion of these specific demographic groups.
This study will admit a wide range of data on the clinical trial experience of Merkel cell carcinoma patients to determine which factors prevail in limiting a patient's ability to join or finish a trial.
It will also try to analyze data from the perspective of different demographic groups to check for recurring trends which might yield insights for the sake of future Merkel cell carcinoma patients.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Aged ≥ 18 years old
Able to comprehend the investigational nature of the protocol and provide informed consent
Diagnosis of Merkel cell carcinoma
Disqualifiers
No diagnosis of Merkel cell carcinoma confirmed
Inability to perform regular electronic reporting
Patient does not understand, sign, and return consent form
Trial population
Patients with Merkel cell carcinoma who are actively considering enrolling in a clinical trial, but have not yet completed enrollment and randomization phases in said clinical trial.
Trial design
Case-crossover
Prospective
Treatments tested in this trial
Not listed
Trial groups
Trial outcomes
Primary outcomes
Number of patients who decide to enroll in a Merkel cell carcinoma clinical research
Rate of patients who remain in Merkel cell carcinoma clinical research to trial completion
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
This trial is not recruiting at the moment. You can still explore other options: